Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

American Stores

  • News

Executive Summary

Jewel Chairman, President, and CEO Richard Cline resigned effective Feb. 3. President of Jewel at the time of the chain's acquisition by American Stores, Cline acceded to the top spot at Jewel on the resignation of former Jewel Chairman and CEO Weston Christopherson following merger agreement. "The transition of Jewel from a public corporation into Am. Stores has been completed and it is now my desire to examine other alternatives," Cline said. He will not assume a seat on the Am Stores board as was planned

Table

View full table

Tags:
Latest Headlines

What’s The Key To Successful R&D With Artificial Intelligence? ‘Bilingual’ Scientists

Pink Sheet Podcast: US FDA Adcomm Reform, Clinical Trial Modeling Boost, AI For Drug Review

US FDA Inspectors, Product Centers Working Closer Together Ahead Of ORA Reorg

Not-For-Profit Models Needed For Commercially Unviable Rare Disease Drugs

See All
UsernamePublicRestriction

Register

PS007794

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By